PPH Legal Blog

Fen-phen, the diet drug wonder of the 1990’s, created many unfortunate and severe health complications in its users, including heart valve damage and primary pulmonary hypertension (PPH).  PPH is a rare and incurable disease which causes increased blood pressure and oxygen depletion in the lungs, forcing many patients to struggle for breath, especially with increased […]

[Read more →]

The lawyers who sued the makers of Fen-Phen on behalf of thousands of plaintiffs have been awarded $412 million for their efforts that spanned nearly a decade.  Federal Judge Harvey Bartle III of Philadelphia awarded the money for more than 578,000 hours of work.  The money is in addition to a $156 million settlement that […]

[Read more →]

Arena Pharmaceuticals is convinced that they can create a weight-loss drug from the same family of drugs as the notorious fen-phen without causing heart valve damage or primary pulmonary hypertension.
A safety review of the drug which involved a 12 month trial shows no heart valve damage or hypertension in patients who participated in the study. […]

[Read more →]

All of the Rezulin diet drug lawsuits have been settled by the drug’s maker except for 187 from Michigan. These 187 cases will be heard by the United States Supreme Court. It is possible because the lawsuit is also challenging Michigan’s pro-drug company legislation which does not allow individuals to sue drug companies for problems […]

[Read more →]

The New York Supreme Court upheld a decision by New York State Judge Charles E. Ramos allowing Parker Waichman Alonso LLP to seek disclosure of documents related to a November 2001 Fen-Phen drug case settlement. The settlement had been negotiated by Napoli, Kaiser & Bern, LLP; Parker Waichman had referred hundreds of its clients to […]

[Read more →]